Basse P - Search Results

1

Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Liang X, De Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer Stolz D, Basse P, Wang T, Van Houten B, Zeh HJ 3rd, Lotze MT. Liang X, et al. Among authors: basse p. Cancer Res. 2012 Jun 1;72(11):2791-801. doi: 10.1158/0008-5472.CAN-12-0320. Epub 2012 Apr 3. Cancer Res. 2012. PMID: 22472122 Free PMC article.

2

In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats.

van den Brink MR, Palomba ML, Basse PH, Hiserodt JC. van den Brink MR, et al. Among authors: basse ph. Cancer Res. 1991 Sep 15;51(18):4931-6. Cancer Res. 1991. PMID: 1893382

3

Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells.

Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH. Basse PH, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):944-50. doi: 10.1093/jnci/83.13.944. J Natl Cancer Inst. 1991. PMID: 2067037

4

Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.

Okada K, Nannmark U, Vujanovic NL, Watkins S, Basse P, Herberman RB, Whiteside TL. Okada K, et al. Among authors: basse p. Cancer Res. 1996 Apr 1;56(7):1599-608. Cancer Res. 1996. PMID: 8603408

5

NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.

Chambers WH, Bozik ME, Brissette-Storkus SC, Basse P, Redgate E, Watkins S, Boggs SS. Chambers WH, et al. Among authors: basse p. Cancer Res. 1996 Aug 1;56(15):3516-25. Cancer Res. 1996. PMID: 8758920

6

Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration.

Hagenaars M, Ensink NG, Koelemij R, Basse PH, Eggermont AM, van de Velde CJ, Fleuren GJ, Kuppen PJ. Hagenaars M, et al. Among authors: basse ph. Int J Cancer. 1998 Jan 19;75(2):233-8. doi: 10.1002/(sici)1097-0215(19980119)75:2<233::aid-ijc11>3.0.co;2-e. Int J Cancer. 1998. PMID: 9462713

7

Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide.

Goldfarb RH, Ohashi M, Brunson KW, Kirii Y, Kotera Y, Basse PH, Kitson RP. Goldfarb RH, et al. Among authors: basse ph. Anticancer Res. 1998 May-Jun;18(3A):1441-6. Anticancer Res. 1998. PMID: 9673353

8

Cancer immunotherapy with interleukin-2-activated natural killer cells.

Basse PH, Whiteside TL, Herberman RB. Basse PH, et al. Mol Biotechnol. 2002 Jun;21(2):161-70. doi: 10.1385/MB:21:2:161. Mol Biotechnol. 2002. PMID: 12059115

9

Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases.

Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC, Goldfarb RH, Herberman RB, Basse PH. Yang Q, et al. Int J Cancer. 2003 Jul 1;105(4):512-9. doi: 10.1002/ijc.11119. Int J Cancer. 2003. PMID: 12712443

10

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB. Kalinski P, et al. Among authors: basse p. Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. doi: 10.1517/14712598.5.10.1303. Expert Opin Biol Ther. 2005. PMID: 16197336 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters